SEC Form 6-K filed by Medicus Pharma Ltd.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of November 2024.
Commission File Number 001-42408
MEDICUS PHARMA LTD.
(Translation of registrant's name into English)
Suite 3400, 100 King St W
Toronto, Ontario, Canada
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
Equinox Gold Corp. |
|
|
|
|
|
Date: November 15, 2024 |
By |
/s/ Raza Bokhari |
|
|
|
Name: Dr. Raza Bokhari |
|
|
|
Title: Executive Chairman and Chief Executive Officer |
INDEX TO EXHIBITS
|
Exhibit |
|
Description |
|
|
||
| 99.2 | Press release, dated November 15, 2024 | |
|
|
||
|
|